PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)

  • Loading...
#14

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Typical
Tracking Error Good
Bid/Ask Ratio Good
Holdings Diversity Typical

Fund Description

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Fund Snapshot Updated 04.15.2014

Previous Close $38.56 Expense Ratio 0.60%
YTD Return 3.86% Avg. 30-Day Volume 178,831
1-Year Return 39.9% Market Cap Loading...
Bid $38.50 Shares Outstanding 9,200,000
Ask $38.53 Dividends $0.00
Top 10 Holdings
Sigma Aldrich Corp (SIAL) 5.75%
Amgen Inc (AMGN) 5.41%
Regeneron Pharmaceuticals (REGN) 5.05%
Biogen Idec Inc (BIIB) 4.89%
Gilead Sciences Inc (GILD) 4.81%
Alexion Pharmaceuticals Inc (ALXN) 4.80%
Illumina Inc (ILMN) 4.46%
Pharmacyclics Inc (PCYC) 3.87%
Myriad Genetics Inc (MYGN) 3.41%
Waters Corp (WAT) 3.14%
% of Total Holdings 45.60%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds